CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,410 | +14.3% | 19,000 | +20.9% | 0.00% | – |
| Q2 2023 | $23,098 | -93.1% | 15,713 | -92.3% | 0.00% | – |
| Q1 2023 | $336,349 | -14.4% | 203,848 | -27.4% | 0.00% | – |
| Q4 2022 | $393,072 | -32.2% | 280,766 | -25.5% | 0.00% | – |
| Q3 2022 | $580,000 | -27.5% | 376,736 | +3.6% | 0.00% | – |
| Q2 2022 | $800,000 | +52.7% | 363,719 | +72.0% | 0.00% | – |
| Q1 2022 | $524,000 | -84.2% | 211,454 | -61.6% | 0.00% | – |
| Q4 2021 | $3,311,000 | +360.5% | 550,974 | +409.7% | 0.00% | – |
| Q3 2021 | $719,000 | -76.9% | 108,100 | -76.9% | 0.00% | – |
| Q2 2021 | $3,109,000 | +1223.0% | 467,461 | +1741.2% | 0.00% | – |
| Q1 2021 | $235,000 | -24.9% | 25,389 | +46.2% | 0.00% | – |
| Q4 2020 | $313,000 | +89.7% | 17,371 | +49.5% | 0.00% | – |
| Q3 2020 | $165,000 | +35.2% | 11,620 | -52.3% | 0.00% | – |
| Q2 2020 | $122,000 | – | 24,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 45,000 | $63 | 0.04% |
| FinDec Wealth Services, Inc. | 16,000 | $22,240 | 0.02% |
| DENVER WEALTH MANAGEMENT, INC. | 18,235 | $25,347 | 0.02% |
| Atom Investors LP | 18,298 | $25,434 | 0.01% |
| Laurion Capital Management LP | 722,100 | $1,003,719 | 0.01% |
| MAI Capital Management | 224,749 | $312,401 | 0.01% |
| Callan Capital, LLC | 31,147 | $43,294 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 25,975 | $36 | 0.00% |
| Tortoise Investment Management, LLC | 15,000 | $20,850 | 0.00% |
| America First Investment Advisors, LLC | 4,000 | $5,560 | 0.00% |